Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jeff W Cramer"'
Autor:
Rongjun He, Jifeng Wang, Zhi-Hong Yu, Julie S. Moyers, M. Dodson Michael, Timothy B. Durham, Jeff W. Cramer, Yuewei Qian, Amy Lin, Li Wu, Nicholas Noinaj, David G. Barrett, Zhong-Yin Zhang
Publikováno v:
J Med Chem
Protein tyrosine phosphatases constitute an important class of drug targets, whose potential has been limited by the paucity of drug-like small molecule inhibitors. We recently described a class of active site-directed, moderately selective and poten
Autor:
Robert J. Konrad, Jessie L. Bishop, Kristin Hollister, Nicoletta Bivi, Margaret A Gardner, Jeff W. Cramer, Michael E Hodsdon, Huy T Nguyen
Publikováno v:
Bioanalysis. 12:1597-1605
Over the developmental lifetime of a therapeutic protein, the immunogenicity assay validation history can become substantial, frustrating review of clinical immunogenicity within the biologics license application. In our experience, this can lead to
Autor:
Robert F. Bruns, Qi Chen, Paloma Vidal, John Mehnert Schaus, Charles R. Yang, Stephen N. Mitchell, Steven Marc Massey, Nuria Diaz, Xushan Wang, David Andrew Coates, Rebecca A. Wright, Beverly A. Heinz, Kevin Matthew Gardinier, Greg Stephenson, James P. Beck, Rajni M. Bhardwaj, Julie F. Falcone, Bruce A. Dressman, Deanna L Maren, Anette M. Johansson, David Michael Remick, Jeff W. Cramer, Cohen Michael Philip, Brian Morgan Watson, Jeffery Richardson, Kjell Svensson, Xin Zhou, Erik James Hembre, Serge Louis Boulet, Reinhard Matthew Robert, Daniel S. Richards, Junliang Hao, David M. Bender, Guy Carter, Christopher David Beadle, Brian G. Getman, Wolfangel Craig Daniel, Diseroad Benjamin Alan, Jason K. Myers, Joseph H. Krushinski, David Edward Tupper
Publikováno v:
Journal of Medicinal Chemistry. 62:8711-8732
Clinical development of catechol-based orthosteric agonists of the dopamine D1 receptor has thus far been unsuccessful due to multiple challenges. To address these issues, we identified LY3154207 (...
Autor:
Junliang, Hao, James P, Beck, John M, Schaus, Joseph H, Krushinski, Qi, Chen, Christopher D, Beadle, Paloma, Vidal, Matthew R, Reinhard, Bruce A, Dressman, Steven M, Massey, Serge L, Boulet, Michael P, Cohen, Brian M, Watson, David, Tupper, Kevin M, Gardinier, Jason, Myers, Anette M, Johansson, Jeffery, Richardson, Daniel S, Richards, Erik J, Hembre, David M, Remick, David A, Coates, Rajni M, Bhardwaj, Benjamin A, Diseroad, David, Bender, Greg, Stephenson, Craig D, Wolfangel, Nuria, Diaz, Brian G, Getman, Xu-Shan, Wang, Beverly A, Heinz, Jeff W, Cramer, Xin, Zhou, Deanna L, Maren, Julie F, Falcone, Rebecca A, Wright, Stephen N, Mitchell, Guy, Carter, Charles R, Yang, Robert F, Bruns, Kjell A, Svensson
Publikováno v:
Journal of medicinal chemistry. 62(19)
Clinical development of catechol-based orthosteric agonists of the dopamine D1 receptor has thus far been unsuccessful due to multiple challenges. To address these issues, we identified LY3154207 (
Autor:
David W. Bedwell, Luc Rougée, Jeff W Cramer, Nathan A Calvert, Nathan Yumibe, Kenneth J. Ruterbories, Kenneth C. Cassidy, Richard Moulton, Michael A. Mohutsky, Lisa A. Adams, Xin Zhou
Publikováno v:
Drug Metabolism and Disposition. 44:1184-1192
The Zucker diabetic fatty (ZDF) rat, an inbred strain of obese Zucker fatty rat, develops early onset of insulin resistance and displays hyperglycemia and hyperlipidemia. The phenotypic changes resemble human type 2 diabetes associated with obesity a
Autor:
Maria Angeles, Martinez-Grau, Isabel C Gonzalez, Valcarcel, Julie V, Early, Richard Klaus, Gessner, Candice Soares, de Melo, Eva Maria Martin, de la Nava, Aaron, Korkegian, Yulia, Ovechkina, Lindsay, Flint, Anisa, Gravelle, Jeff W, Cramer, Prashant V, Desai, Leslie J, Street, Joshua, Odingo, Thierry, Masquelin, Kelly, Chibale, Tanya, Parish
Publikováno v:
Bioorganic & Medicinal Chemistry Letters
Graphical abstract
Highlights • We conducted SAR for the aryl-oxadiazole series with anti-bacterial activity against Mycobacterium tuberculosis. • Improved compounds have sub-micromolar butyrate-specific activity. • Compounds are not cytot
Highlights • We conducted SAR for the aryl-oxadiazole series with anti-bacterial activity against Mycobacterium tuberculosis. • Improved compounds have sub-micromolar butyrate-specific activity. • Compounds are not cytot
Publikováno v:
Pharmacology Biochemistry and Behavior. 112:1-8
Serotonin acts through receptors controlling several physiological functions, including energy homeostasis regulation and food intake. Recent experiments demonstrated that 5-HT1A receptor antagonists reduce food intake. We sought to examine the micro
Autor:
Claire V. Cella, Jenna Hanmer, Michael Hutton, David O. Calligaro, Aaron Simmons, Annalisa Cavallini, Peter Davies, Hugh Nuthall, Laura J. Bloem, Philip G. Szekeres, Michael J. O'Neill, Suchira Bose, Mark A Ward, Helen Sims, Jeff W. Cramer, Tracey K. Murray, Elizabeth Eberle, Lisa Baschirotto, Dan L. Czilli, Ana I. Mateo, Michel Goedert, Sandra Sossick
Publikováno v:
Alzheimer's & Dementia. 8
Background: Neurofibrillary tangles (NFT), one of the hallmarks of Alzheimer’s disease (AD), are composed of paired helical filaments (PHF) of abnormally hyperphosphorylated tau. The accumulation of these proteinaceous aggregates in AD correlates w
Autor:
Calderon, Boris, Reynolds, Nichole A, Swearingen, Craig A, Carter, Quincy L, Bivi, Nicoletta, Cramer, Jeff W, Alexander, Courtney L, Siegel, Robert W, Konrad, Robert J
Publikováno v:
Journal of Applied Laboratory Medicine; Sep2023, Vol. 8 Issue 5, p896-908, 13p